Details for Patent: 5,338,732
✉ Email this page to a colleague
Summary for Patent: 5,338,732
Title: | Megestrol acetate formulation |
Abstract: | The present invention relates to a novel oral pharmaceutical composition of micronized megestrol acetate at a concentration of 15 to 150 mg/mL comprising polysorbate at a concentration of 0.005% to 0.015% weight/volume and polyethylene glycol at a concentration of 5-30% weight/volume which composition forms a stable flocculated suspension in water. The invention further comprises the micronized megestrol acetate formulation described above with added preservatives, buffers, sweeteners and flavoring agents. |
Inventor(s): | Atzinger; Anne E. (Lebanon, IN), Bequette; Robert J. (Evansville, IN), Davis; Robert E. (Evansville, IN) |
Assignee: | Bristol-Myers Squibb Company (New York, NY) |
Application Number: | 07/882,218 |
Patent Claim Types: see list of patent claims | Composition; |
Drugs Protected by US Patent 5,338,732
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,338,732
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 142882 | ⤷ Try a Trial | |||
Australia | 1828192 | ⤷ Try a Trial | |||
Australia | 647933 | ⤷ Try a Trial | |||
Canada | 2071141 | ⤷ Try a Trial | |||
China | 1038904 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |